Latest News

Quotient Sciences has been recognized as a finalist for a special category award, "Best Innovative Approach to Technology and Process Execution," in the 2025 CDMO Leadership Awards

The global OSD contract manufacturing market is projected to grow, however, the sector faces challenges and is constantly evolving.

Quotient Sciences has been recognized as a 2025 CDMO Leadership Awards winner in the category of Small Molecule Dosage Form – Global. The company is also a finalist for a champion award in the same category, to be presented in March. The CD...

Thoughtful design and development of drug products are vital for ensuring patient acceptability and compliance, which ultimately contribute to achieving the desired clinical outcomes. In a recent article with PharmTech, Nazim Kanji, Executi...

Quotient Sciences, a leading global pharmaceutical drug development and manufacturing accelerator, is proud to announce the successful completion of an inspection and registration with the Chinese regulatory authority.  This is the...